Additionally, decreased levels of two CLL signature miRNAs miR-29c and miR-223 are associated with ZAP70+ and IgVH unmutated status and with shorter time to first therapy. The gene discussed is ZAP70; the disease is B-cell chronic lymphocytic leukemia.